Carol Sze Ki Leung

6PUBLICATIONS
25CO-AUTHORS
Molecular targetsNon-Newtonian fluid flows (incl. rheology)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 03, 2026
Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF.

Biao Ma, Wenxin Lyu, John Rizk

|Oct 09, 2024
Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice.

James McAuliffe, Silvia Panetti, Emily Steffke

|Sep 04, 2021
Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy.

James McAuliffe, Hok Fung Chan, Laurine Noblecourt

|Jul 17, 2018
Immunotherapy and Vaccine Development.

Carol Leung, Christian Münz, Angelika Riemer

Pageof 1